American Oncology Institute (AOI) in Mangalagiri, Vijayawada, is pleased to announce the successful treatment of a 42-year-old female patient from Guntur diagnosed with locally advanced breast cancer. The patient was presented with a lump in her right breast for six months, which measured 3.5×2.
5 cm, along with palpable lymph nodes in the right axilla. Upon evaluation, a biopsy confirmed the diagnosis of ductal carcinoma. Given the advanced stage 3B triple-negative breast cancer, the patient was started on neoadjuvant chemotherapy to shrink the tumor and evaluate the response post-surgery.
An ultrasound after chemotherapy revealed no remaining tumor. Recently, the patient underwent a modified radical mastectomy of the right breast. The report post-surgery indicated no residual tumor, a strong indicator of a good prognosis.
The patient is currently receiving adjuvant radiation therapy and will be under regular follow-up to monitor her health. Dr Srujana Joga, Medical Oncologist, AOI Vijayawada commented, “Administering chemotherapy before surgery is the standard of care in early and locally advanced triple-negative breast cancers. While all triple-negative breast cancers do not have the same prognosis, in this case, the patient's complete response after chemotherapy and surgery confirms a good prognosis.
This outcome is a testament to the advanced and personalized care provided at our institute.” Mahendra Reddy, RCOO of AOI Vijayawada, stated, “At American Oncology Inst.
